Wound spray

US10646613B2 · kind B2 · utility

Assignee

• Mölnlycke Health Care AB · SE

Inventors

• Michael Sander · Blankenloch, DE
• Harald Potzschke · Wiesbaden, DE

Key dates

• Filing date: Jul 23, 2012
• Grant date: May 12, 2020
• Expiry date: Jul 23, 2032

Classification

• Technology area (CPC F): Mechanical Engineering; Lighting; Heating
• CPC primary: F04C2270/041
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention refers to a composition, comprising hemoglobin or myoglobin, wherein in at least 40% of said hemoglobin or myoglobin the oxygen binding site is charged by a non-O2 ligand, and at least one further ingredient, a method for preparing said composition and the use of hemoglobin or myoglobin charged with a non-oxygen ligand for external treatment of wounds.